Advertisement

Response

      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Atack JR
        • Broughton HB
        • Pollack SJ
        Inositol monophosphatase—a putative target for Li+ in the treatment of bipolar disorder.
        Trends Neurosci. 1995; 18: 343-349
        • Deicken RF
        • Fein G
        • Weiner MW
        Abnormal frontal lobe phosphorus metabolism in bipolar disorder.
        Am J Psychiatry. 1995; 152: 915-918
        • Deicken RF
        • Weiner MW
        • Fein G
        Decreased temporal lobe phosphomonoesters in bipolar disorder.
        J Affect Disorders. 1995; 33: 195-199
        • Gyulai L
        • Bolinger L
        • Leigh JS
        • Barlow C
        • Chance B
        Phosphorylethanolamine—The major constituent of the phosphomonoester peak observed by 31P-NMR on developing dog brain.
        FEBS Lett. 1984; 178: 137-142
        • Jope RS
        • Williams MB
        Lithium and brain signal transduction systems.
        Biochem Pharmacol. 1994; 47: 429-441
        • Joseph NE
        • Renshaw PF
        • Leigh JS
        Systemic lithium administration alters rat cerebral cortex phospholipids.
        Biol Psychiatry. 1987; 22: 540-544
        • Kato T
        • Shioiri T
        • Takahashi S
        • Inubushi T
        Measurement of brain phosphoinositide metabolism in bipolar patients using in vivo 31P-MRS.
        J Affective Disorders. 1991; 22: 185-190
        • Kato T
        • Takahashi S
        • Shioiri T
        • Inubushi T
        Brain phosphorus metabolism in depressive disorders by phosphorus-31 magnetic resonance spectroscopy.
        J Affect Disorders. 1992; 26: 223-230
        • Kato T
        • Takahashi S
        • Shioiri T
        • Inubushi T
        Alterations in brain phosphorus metabolism in bipolar disorder detected by in vivo 31P and 7Li magnetic resonance spectroscopy.
        J Affect Disorders. 1993; 27: 53-60
        • Kato T
        • Shioiri T
        • Murashita J
        • Hamakawa H
        • Inubushi T
        • Takahashi S
        Phosphorus-31 magnetic resonance spectroscopy and ventricular enlargement in bipolar disorder.
        Psychiatry Res. 1994; 55: 41-50
        • Kato T
        • Takahashi S
        • Shioiri T
        • Murashita J
        • Hamakawa H
        • Inubushi T
        Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy.
        J Affect Disorders. 1994; 31: 125-133
        • Navidi M
        • Yoa FG
        • Sun GY
        Brief chronic effects of lithium administration on rat brain phosphoinositides and phospholipids.
        J Neurosci Res. 1991; 28: 428-433
        • Preece NE
        • Gadian DG
        • Houseman J
        • Williams SR
        Lithium-induced modulation of cerebral inositol phosphate metabolism in the rat: A multinuclear magnetic resonance study in vivo.
        Lithium. 1992; 3: 287-297
        • Renshaw PF
        • Summers JJ
        • Renshaw CE
        • Hines KG
        • Leigh Jr, JS
        Changes in the 31P-NMR spectra of cats receiving lithium chloride systemically.
        Biol Psychiatry. 1986; 21: 694-698